Biology Reference
In-Depth Information
Jewett A, Cavacanti M, Giorgi J, Bonavida B. 1997. Concomitant killing in vitro of both gp120-
coated CD4
peripheral T lymphocytes and NK cells in the antibody-dependent cellular cyto-
toxicity (ADCC) system. J Immunol 158: 5492±5500.
Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B. 1987. Mechanism of defective NK
cell activity in patients with acquired immunode®ency syndrome (AIDS) and AIDS-related
complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by e¨ector
cells defective in natural killer (NK) cytotoxicity. J Immunol 139: 55±60.
Katz JD, Nishanian P, Mitsuyasu R, Bonavida B. 1988. Antibody-dependent cellular cytotoxicity
(ADCC)-mediated destruction of human immunode®ciency virus (HIV)-coated CD4
T lym-
phocytes by acquired immunode®ciency syndrome (AIDS) e¨ector cells. J Clin Immunol 8: 453±
458.
Landay A, Ohlsson-Wilhelm B, Giorgi JV. 1990. Application of ¯ow cytometry to the study of HIV
infection. AIDS 6: 479±497.
Lanier LL. 1998. Activating and inhibitory NK cell receptors. Adv Exp Med Biol 452: 13±18.
Lanier LL. 2001. On guard-activating NK cell receptors. Nat Immunol 2: 23±28.
Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. 1986. The relationship of CD16 (Leu-11)
and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T
lymphocytes. J Immunol 136: 4480±4486.
Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. 1998. Immunoreceptor DAP12 bearing a
tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703±707.
Lebow LT, Bonavida B. 1990. Puri®cation and characterization of cytolytic and noncytolytic
human natural killer cell subsets. Proc Natl Acad Sci USA 87: 6063±6067.
Liu Y, Janeway Jr CA. 1990. Interferon gamma plays a critical role in induced cell death of e¨ector
T cell: a possible third mechanism of self-tolerance. J Exp Med 172: 1735±1739.
Ljunggren K, Karlson A, Fenyo EM, Jondal M. 1989. Natural and antibody-dependent cytotox-
icity in di¨erent clinical stages of human immunode®ciency virus type 1 infection. Clin Exp
Immunol 75: 184±189.
Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. 1996. Activation of NK cells by CC
chemokines. Chemotaxis, Ca2
mobilization, and enzyme release. J Immunol 156: 322±327.
Mansour I, Doinel C, Rouger P. 1990. CD16
NK cells decrease in all stages of HIV infection
through a selective depletion of the CD16
CD8
CD3
ÿ
subset. AIDS Res Hum Retroviruses 6:
1451±1457.
Margolick JB, Scott ER, Odaka N, Saah AJ. 1991. Flow cytometric analysis of gamma delta T cells
and natural killer cells in HIV-1 infection. Clin Immunol Immunopathol 58: 126±138.
Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. 2000. Natural cytotoxicity receptors
that trigger human NK-cell-mediated cytolysis. Immunol Today 21: 228±234.
Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B. 1997. The participation of the
Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol
Immunother 44: 282±290.
Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Im-
munol 12: 593±633.
Nair MP, Schwartz SA. 1997. Inhibition of natural killer cell activities from normal donors and
AIDS patients by envelope peptides from human immunode®ciency virus type I. Cell Mol Biol
43: 969±979.
Nair MP, Saravolatz LD, Schwartz SA. 1995. Selective inhibitory e¨ects of stress hormones on
natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol Invest 24: 689±
699.
Ojo-Amaize E, Nishanian PG, Heitjan DF, Rezai A, Esmail I, Korns E, Detels R, Fahey J, Giorgi
JV. 1989. Serum and e¨ector-cell antibody-dependent cellular cytotoxicity (ADCC) activity re-
mains high during human immunode®ciency virus (HIV) disease progression. J Clin Immunol 9:
454±461.
